Skip to content

Cannabis Use Patterns Among Cancer Patients

Determining Patterns of Cannabis Use Among Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05132842
Enrollment
1568
Registered
2021-11-24
Start date
2021-02-25
Completion date
2022-10-29
Last updated
2025-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

Brief summary

This study determines patterns of cannabis use among cancer patients. Information collected in this study may help doctors to understand patient use of cannabis therapy, their knowledge and experiences with this therapy, benefits and risks associated with its use, and whether or to what extent they are discussing it with their health care providers.

Detailed description

PRIMARY OBJECTIVES: I. To identify the frequency, modes, and duration of cannabis use, assess experiences with obtaining and using cannabis, as well as reasons for use and perceived risks and benefits of its use among cancer patients who are undergoing or have recently completed active treatment. Ia. To uncover disparities in use of cannabis, perceptions of use, and communication with providers among cancer patients who are identify as racial and ethnic minorities, have low health or digital literacy, are of older age or low socioeconomic status. II. Among cancer patients with a known medical marijuana certification, assess the impact of cannabis on pain management, anxiety, anorexia, and quality of life, as well as their communication with their oncology team about their procurement and use of cannabis. OUTLINE: Patients complete a survey about knowledge and awareness of medical cannabis, perceived risks and benefits of cannabis, mode and frequency of use (if applicable), impact on cancer-related symptoms, patient provider discussions about cannabis, and demographic characteristics including health and digital literacy.

Interventions

OTHERSurvey Administration

Complete a Survey

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Thomas Jefferson University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provide signed and dated informed consent form * English speaking * Willing to comply with all study procedures and be available for the duration of the study * Any individual \>= 18 years old * At least one medical or radiation oncology appoint within the last 3 years at one of the SKCC cancer center campuses

Exclusion criteria

* Non-English speaking * Not a cancer patient at one of the SKCC campuses * Deceased

Design outcomes

Primary

MeasureTime frameDescription
Survey data analysisUp to 12 monthsRespondent demographics and clinical characteristics and survey responses

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026